The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,846.00
Bid: 1,832.00
Ask: 1,834.00
Change: 43.00 (2.38%)
Spread: 2.00 (0.109%)
Open: 1,819.00
High: 1,846.00
Low: 1,809.00
Prev. Close: 1,803.00
IMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Jan 2024 11:02

RNS Number : 3843B
IMI PLC
30 January 2024
 

30 January 2024

IMI plc

Future Board change

Jamie Pike to succeed Lord Smith of Kelvin as Chair

IMI plc (the "Company" or "IMI") today announces that Jamie Pike will be appointed as Chair of the IMI Board and the Nomination Committee with effect from 1 January 2025 following a comprehensive selection process and as part of its orderly succession planning activities. Lord Smith of Kelvin will seek re-election at the 2024 Annual General Meeting to facilitate a smooth transition and will step down from the Board on 31 December 2024. Lord Smith joined the Board in 2015.

Jamie joined Burmah Castrol in 1991 and was Chief Executive of Burmah Castrol Chemicals before leading the buy-out of Foseco in 2001 and its subsequent flotation in 2005. Prior to joining Burmah, he was a partner at Bain & Company. Jamie was educated at Oxford, holds an MBA from INSEAD and is a Member of the Institute of Mechanical Engineers. He has previously held roles as Chair of Cobham plc and RPC Group plc. Jamie currently holds the positions of Chair of Spirax-Sarco Engineering plc and Chair of XP Power Limited. As previously announced by Spirax-Sarco Engineering plc, Jamie will be standing down from that position during 2024 following the expiry of his nine years as a director.

Roy Twite, Chief Executive Officer said: "We are delighted that Jamie is joining the Board and taking on the role of Chair next year. He brings a wealth of listed board experience and a deep understanding of engineering. I am very much looking forward to working with him.

I would also like to take this early opportunity to thank Lord Smith of Kelvin. He has been an outstanding Chair and IMI has benefited tremendously from his guidance and support over the last nine years."

Lord Smith of Kelvin, Chair said: "It has been a privilege to work with so many talented colleagues at IMI for the last nine years and to see the Group make significant progress in this time. I am confident that IMI will be in good hands with Jamie as my successor."

Jamie Pike, incoming Chair, commented: "I am excited to be joining the team at IMI. The Company has a clear strategy rooted in its purpose of breakthrough engineering for a better world. Under Roy's leadership, the business has been transformed and I am looking forward to working with the Board and wider team to continue creating value for all of IMI's stakeholders. "

This announcement has been made in accordance with the requirements of Listing Rule 9.6.11. There is no further information to be disclosed under Listing Rule 9.6.13.

Enquiries

Louise Waldek Company Secretary Tel: 0121 717 3700

Luke Grant Head of Investor Relations Tel: +44 (0)7866 148 374

Matt Denham Headland Tel: +44 (0)7551 825 496

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFBLFXZFLBBBF
Date   Source Headline
6th May 20215:12 pmRNSTransaction in Own Shares
6th May 20212:39 pmRNSResult of AGM
4th May 20215:30 pmRNSTransaction in Own Shares
4th May 20214:42 pmRNSTotal Voting Rights
4th May 202110:15 amRNSHolding(s) in Company
30th Apr 20216:28 pmRNSTransaction in Own Shares
29th Apr 20215:20 pmRNSTransaction in Own Shares
29th Apr 20215:16 pmRNSTransaction in Own Shares - Replacement
29th Apr 20215:15 pmRNSTransaction in Own Shares - Replacement
27th Apr 20215:28 pmRNSHolding(s) in Company
27th Apr 20215:02 pmRNSTransaction in Own Shares
26th Apr 20216:20 pmRNSTransaction in Own Shares
26th Apr 202111:23 amRNSShare repurchase programme
26th Apr 20217:00 amRNSInterim Management Statement
14th Apr 20219:17 amRNSDirector/PDMR Shareholding
9th Apr 20214:15 pmRNSDirector/PDMR Shareholding
1st Apr 202110:26 amRNSDirector/PDMR Shareholding
1st Apr 202110:20 amRNSTotal Voting Rights
31st Mar 202110:42 amRNSDirector/PDMR Shareholding
26th Mar 20213:38 pmRNSAnnual Financial Report
23rd Mar 20211:52 pmRNSDirector/PDMR Shareholding
23rd Mar 202110:56 amRNSDirector Declaration
19th Mar 20214:17 pmRNSDirector/PDMR Shareholding
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
1st Mar 202110:09 amRNSTotal Voting Rights
26th Feb 20219:04 amRNSHolding(s) in Company
26th Feb 20217:08 amRNSNew non-executive director appointed
26th Feb 20217:00 amRNSPreliminary results, year ended 31 December 2020
17th Feb 20216:13 pmRNSHolding(s) in Company
15th Feb 20214:17 pmRNSHolding(s) in Company
10th Feb 202112:38 pmRNSDirector/PDMR Shareholding
1st Feb 202110:26 amRNSTotal Voting Rights
13th Jan 202111:29 amRNSDirector/PDMR Shareholding
5th Jan 202110:04 amRNSBlock listing Interim Review
4th Jan 202110:54 amRNSTotal Voting Rights
9th Dec 202010:16 amRNSDirector/PDMR Shareholding
1st Dec 20209:24 amRNSTotal Voting Rights
11th Nov 202011:26 amRNSDirector/PDMR Shareholding
2nd Nov 20209:29 amRNSTotal Voting Rights
28th Oct 20207:00 amRNSInterim Management Statement
14th Oct 202012:07 pmRNSDirector/PDMR Shareholding
1st Oct 20209:33 amRNSTotal Voting Rights
9th Sep 20205:04 pmRNSDirector/PDMR Shareholding
9th Sep 202012:32 pmRNSDirector/PDMR Shareholding
7th Sep 20209:07 amRNSHolding(s) in Company
1st Sep 202010:04 amRNSTotal Voting Rights
12th Aug 20204:01 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:28 amRNSTotal Voting Rights
28th Jul 202011:33 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSInterim results, six months ended 30 June 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.